Shattuck Labs Reports Q3 GAAP EPS Miss Amid Increased Cash Reserves
Shattuck Labs (STTK) reported third-quarter GAAP earnings per share of -$0.14, missing analyst expectations by $0.04. Despite the earnings miss, the company demonstrated significant growth in its liquidity position. As of September 30, 2026, Shattuck Labs held $196.3 million in cash, cash equivalents, and short-term investments, a substantial increase from the $86.1 million reported as of September 30, 2025. The company remains positioned within the emerging immunology sector, specifically focusing on receptor-side developments related to TL1A.
Topics: cash position earnings miss financial results
Read the full article at Seeking Alpha
Part of the story Sensei Biotherapeutics Reports Q3 GAAP EPS of -$0.79, Slightly Missing Estimates (8 articles)